001433786 000__ 03699cam\a2200529\a\4500
001433786 001__ 1433786
001433786 003__ OCoLC
001433786 005__ 20230309003653.0
001433786 006__ m\\\\\o\\d\\\\\\\\
001433786 007__ cr\un\nnnunnun
001433786 008__ 210209s2020\\\\sz\\\\\\o\\\\\001\0\eng\d
001433786 020__ $$a9783030581749$$q(electronic bk.)
001433786 020__ $$a3030581748$$q(electronic bk.)
001433786 020__ $$z303058173X
001433786 020__ $$z9783030581732
001433786 0247_ $$a10.1007/978-3-030-58174-9$$2doi
001433786 035__ $$aSP(OCoLC)1236917600
001433786 040__ $$aYDX$$beng$$epn$$cYDX$$dGW5XE$$dOCLCO$$dOCLCF$$dUKAHL$$dAHH$$dOCLCO$$dOCLCQ$$dOCLCO$$dOCLCQ$$dCASUM
001433786 049__ $$aISEA
001433786 050_4 $$aRC270.8
001433786 08204 $$a616.9/9406$$223
001433786 08204 $$a610.28$$223
001433786 24500 $$aBio-nanomedicine for cancer therapy /$$cFlavia Fontana, Hélder  A. Santos, editors.
001433786 260__ $$aCham :$$bSpringer,$$c2020.
001433786 300__ $$a1 online resource
001433786 336__ $$atext$$btxt$$2rdacontent
001433786 337__ $$acomputer$$bc$$2rdamedia
001433786 338__ $$aonline resource$$bcr$$2rdacarrier
001433786 4901_ $$aAdvances in experimental medicine and biology,$$x0065-2598 ;$$vv. 1295
001433786 500__ $$aIncludes index.
001433786 5050_ $$aPart 1 -- Conventional nanosized drug delivery systems for cancer applications -- Homing peptides for cancer therapy -- Radiolabeling of theranostic nanosystems -- Boosting nanomedicine efficacy with hyperbaric oxygen therapy -- Part 2 -- Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy -- Clearable Nanoparticles for Cancer Photothermal Therapy -- Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds -- Electrospun Nanofibers for Cancer Therapy -- Nanoneedle-based materials for intracellular studies -- Part 3 -- In vitro assays for nanoparticle-cancer cell interaction studies -- 3D tumor spheroid models for in vitro therapeutic screening of nanoparticles -- In vitro and in vivo tumor models for the evaluation of anticancer nanoparticles -- Part 4 -- Nanotechnology for the Development of Nanovaccines in Cancer Immunotherapy -- Viral nanoparticles: cancer vaccines and immune modulators -- Industrial Perspective on Cancer Immunotherapy -- Index.
001433786 506__ $$aAccess limited to authorized users.
001433786 520__ $$aThe book covers the latest developments in biologically-inspired and derived nanomedicine for cancer therapy. The purpose of the book is to illustrate the significance of naturally-mimicking systems for enhancing the dose delivered to the tumor, to improve stability, and prolong the circulation time. Moreover, readers are presented with advanced materials such as adjuvants for immunostimulation in cancer vaccines. The book also provides a comprehensive overview of the current status of academic research. This is an ideal book for students, researchers, and professors working in nanotechnology, cancer, targeted drug delivery, controlled drug release, materials science, and biomaterials as well as companies developing cancer immunotherapy.
001433786 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed March 17, 2021).
001433786 650_0 $$aCancer$$xTreatment$$xTechnological innovations.
001433786 650_0 $$aNanomedicine.
001433786 655_0 $$aElectronic books.
001433786 7001_ $$aFontana, Flavia,$$eeditor.
001433786 7001_ $$aSantos, Hélder A.,$$eeditor.
001433786 77608 $$iPrint version:$$tBio-nanomedicine for cancer therapy.$$dCham : Springer, 2020$$z303058173X$$z9783030581732$$w(OCoLC)1180973062
001433786 830_0 $$aAdvances in experimental medicine and biology ;$$vv. 1295.$$x0065-2598
001433786 852__ $$bebk
001433786 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-58174-9$$zOnline Access$$91397441.1
001433786 909CO $$ooai:library.usi.edu:1433786$$pGLOBAL_SET
001433786 980__ $$aBIB
001433786 980__ $$aEBOOK
001433786 982__ $$aEbook
001433786 983__ $$aOnline
001433786 994__ $$a92$$bISE